Sep 07, 2016 11:00 am UTC| Business
CARMIEL, Israel, Sept. 07, 2016 -- Protalix BioTherapeutics, Inc.(NYSE MKT:PLX) (TASE:PLX), announced today an oral presentation highlighting the results of the phase I/II clinical trial of PRX-102 for the treatment of...
Sep 07, 2016 11:00 am UTC| Business
PLEASANTON, Calif., Sept. 07, 2016 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference in...
Summit Therapeutics to Present at 18th Annual Rodman & Renshaw Global Investment Conference
Sep 07, 2016 11:00 am UTC| Business
OXFORD, United Kingdom, Sept. 07, 2016 -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile...
HMS Holdings Acquires Essette – A Web-based Care Management Technology Platform
Sep 07, 2016 11:00 am UTC| Business
IRVING, Texas, Sept. 07, 2016 -- HMS Holdings Corp. (NASDAQ:HMSY) today announced the acquisition of Essette, a web-based care management platform which helps risk-bearing healthcare organizations identify, engage, and...
Sep 07, 2016 11:00 am UTC| Business
HIGHLANDS RANCH, Colo., Sept. 07, 2016 -- Arcadis North America announced today it has been awarded a 10-year, multi-million dollar contract by a leading energy company to provide soil and groundwater remediation at...
GW Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
Sep 07, 2016 11:00 am UTC| Business
LONDON, Sept. 07, 2016 -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its...
Sep 07, 2016 11:00 am UTC| Business
NEW YORK, Sept. 07, 2016 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of...